Scotiabank Increases Bionano Genomics (NASDAQ:BNGO) Price Target to $4.00

Bionano Genomics (NASDAQ:BNGO) had its price target lifted by Scotiabank from $1.00 to $4.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has a sector perform rating on the stock.

Bionano Genomics Trading Up 21.0 %

NASDAQ:BNGO opened at $3.75 on Wednesday. Bionano Genomics has a 52-week low of $2.68 and a 52-week high of $72.60. The company has a quick ratio of 0.99, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The stock has a fifty day simple moving average of $4.54 and a 200-day simple moving average of $12.91. The company has a market capitalization of $10.25 million, a PE ratio of -0.03 and a beta of 2.24.

Institutional Investors Weigh In On Bionano Genomics

A number of institutional investors have recently bought and sold shares of the stock. Geode Capital Management LLC boosted its holdings in shares of Bionano Genomics by 47.3% in the 3rd quarter. Geode Capital Management LLC now owns 882,854 shares of the company’s stock valued at $401,000 after purchasing an additional 283,639 shares during the last quarter. Carret Asset Management LLC increased its stake in Bionano Genomics by 39.9% during the fourth quarter. Carret Asset Management LLC now owns 119,000 shares of the company’s stock worth $34,000 after acquiring an additional 33,945 shares during the last quarter. Renaissance Technologies LLC purchased a new position in shares of Bionano Genomics in the 4th quarter worth about $46,000. XTX Topco Ltd acquired a new position in shares of Bionano Genomics in the 4th quarter valued at about $45,000. Finally, Jane Street Group LLC purchased a new stake in shares of Bionano Genomics during the 4th quarter worth about $118,000. 11.35% of the stock is currently owned by hedge funds and other institutional investors.

Bionano Genomics Company Profile

Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.